PALVELLA THERAPEUTICS INC NE COM is a security (CUSIP 697947109) tracked across SEC portfolio filings. 189 institutional managers reported $1.7B on Form 13F as of 2026-06-30; 27 registered fund positions totaling $110.0M via N-PORT as of 2026-05-31.
Showing 15 of 189 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| JENNISON ASSOCIATES LLC | NEW YORK, NY | $146.8M | 960,619 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | New York, NY | $143.8M | 1,153,496 |
| First Light Asset Management, LLC | Edina, MN | $122.3M | 980,758 |
| BVF INC/IL | San Francisco, CA | $119.8M | 960,989 |
| Frazier Life Sciences Management, L.P. | MENLO PARK, CA | $110.0M | 882,400 |
| BlackRock, Inc. | New York, NY | $85.6M | 686,853 |
| VANGUARD GROUP INC | Valley Forge, PA | $58.7M | 560,616 |
| STATE STREET CORP | BOSTON, MA | $57.2M | 458,999 |
| FEDERATED HERMES, INC. | Pittsburgh, PA | $54.0M | 433,015 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | Boston, MA | $46.6M | 374,035 |
| Woodline Partners LP | San Francisco, CA | $39.6M | 317,517 |
| EMERALD ADVISERS, LLC | LEOLA, PA | $35.1M | 229,486 |
| Siren, L.L.C. | New York, NY | $32.1M | 257,485 |
| Caption Management, LLC | OKLAHOMA CITY, OK | $29.6M | — |
| EVENTIDE ASSET MANAGEMENT, LLC | Boston, MA | $29.0M | 233,248 |
Showing 15 of 27 fund positions by value.
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| PGIM Jennison Health Sciences Fund | Prudential Sector Funds, Inc. | $21.7M | 156.15% |
| T. Rowe Price Health Sciences Fund, Inc. | T. ROWE PRICE HEALTH SCIENCES FUND, INC. | $19.1M | 17.52% |
| VANGUARD EXTENDED MARKET INDEX FUND | VANGUARD INDEX FUNDS | $12.9M | 1.58% |
| T. Rowe Price New Horizons Fund, Inc. | T. ROWE PRICE NEW HORIZONS FUND, INC. | $10.2M | 7.99% |
| abrdn Healthcare Investors | abrdn Healthcare Investors | $6.8M | 60.03% |
| Emerald Growth Fund | FINANCIAL INVESTORS TRUST | $6.7M | 47.48% |
| PGIM Jennison Small Company Fund | Prudential Jennison Small Co Fund, Inc. | $6.6M | 20.83% |
| VANGUARD RUSSELL 2000 INDEX FUND | VANGUARD SCOTTSDALE FUNDS | $4.7M | 2.69% |
| abrdn Life Sciences Investors | abrdn Life Sciences Investors | $3.3M | 58.50% |
| VANGUARD U.S. MOMENTUM FACTOR ETF | VANGUARD WELLINGTON FUND | $2.7M | 14.80% |
| Small Cap Core Portfolio | Bernstein Fund Inc | $2.7M | 37.68% |
| BlackRock Health Sciences Term Trust | BlackRock Health Sciences Term Trust | $2.6M | 26.16% |
| PGIM Jennison Blend Fund | Prudential Jennison Blend Fund, Inc. | $1.5M | 12.95% |
| ROYCE SMALL-CAP TRUST, INC. | ROYCE SMALL-CAP TRUST, INC. | $1.5M | 6.71% |
| Master Small Cap Index Series | Quantitative Master Series LLC | $1.5M | 3.07% |